[Federal Register Volume 64, Number 75 (Tuesday, April 20, 1999)]
[Notices]
[Page 19368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-9822]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC); 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meetings.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times and Dates: 8:30 a.m.-5 p.m., May 12, 1999; 8:30 a.m.-3:30 
p.m., May 13, 1999.
    Place: CDC, Koger Center, Williams Building, Conference Rooms 
1802 and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting rooms accommodate approximately 85 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact of proposed revisions to the standards; and the modification 
of the standards to accommodate technological advances.
    Matters To Be Discussed: The morning session of the first day 
will be devoted to orientation of new members. The orientation is 
background and process for new committee members. Although members 
of the public may attend, the orientation is not part of the public 
meeting. The agenda will include an update on CLIA implementation; 
update on transfer of test categorization and review of tests for 
waived status to the FDA; CLIA requirements and laboratory test 
results of public health importance; and remaining gaps in 
laboratory Y2K preparedness.
    The Committee solicits oral and written testimony on the 
application of CLIA regulations and laboratory test results of 
public health importance. Requests to make an oral presentation 
should be submitted in writing to the contact person listed below by 
close of business, May 7, 1999. All requests to make oral comments 
should contain the name, address, telephone number, and 
organizational affiliation of the presenter. Written comments should 
not exceed five single-spaced typed pages in length and should be 
received by the contact person listed below by close of business, 
May 7, 1999.
    Agenda items are subject to change as priorities dictate.
    Contact Person for Additional Information: John C. Ridderhof, 
Dr.P.H., Division of Laboratory Systems, Public Health Practice 
Program Office, CDC, 4770 Buford Highway, NE, M/S G-25, Atlanta, 
Georgia 30341-3724, telephone 770/488-8076, fax 770/488-8282.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and ATSDR.

    Dated: April 13, 1999.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-9822 Filed 4-19-99; 8:45 am]
BILLING CODE 4163-18-P